NCT05895175

Brief Summary

Recently, many families have been formed through gamete donation, a reproductive treatment where the ensuing children do not share a genetic link with either parents. However, despite such an increase, little is known about the parent-child relationship. Indeed, only two longitudinal studies have provided scientific background about family functioning in gamete donation. These studies showed that in egg donation families, the parent-child relationship was normal for parenting, parent psychological health, and child adjustment. A more recent study evaluated mother-infant interaction in egg donation families comparing them with those created through IVF with their own gametes. Data collected showed that in egg donation families the mother-infant relationship quality appeared to be less optimal. Mothers were less interactive and stimulating, and infants showed lower involvement and less responsiveness with respect to their mothers Overall, the evidence suggests that women conceiving through egg donation likely require a variable period of adaptation to parenting. Here, the investigators aim to evaluate this interaction at an earlier stage, that is during the gestation. The specific bond that parents develop towards the fetus during pregnancy is called "parental-fetus attachment". Previous studies showed that the quality of the parental-fetus attachment is predictive of the quality of the postnatal parent-infant relationship and the child development The purpose is to evaluate whether the lack of genetic link with their offspring could undermine the parental attachment to the fetus, comparing couples conceiving through egg donation with those who get pregnant through a standard IVF treatment with their own gametes. No studies have been performed so far on this matter. To assess the mother-father fetus attachment, the investigators will administer standardized and validated questionnaires to couples undergoing IVF with their own gametes, or egg donation cycles. For women, the investigators will use the Maternal Antenatal Attachment Scale . For men, the investigators will use the Paternal Antenatal Attachment Scale (PAAS-IT) . Furthermore, to also assess the emotional status of both partners, the investigators will use the Matthey Generic Mood Questionnaire . Seeing that in the general population the maternal-fetal attachment level increases once women have completed the principal prenatal genetic screenings (like NIPT, CVS or amnio) and once they start perceiving the fetal movements, the investigators will administer the same questionnaire twice: between the 19-23 weeks and between the 28-32 weeks of gestation. This approach will enable monitoring of the evolution of the maternal and paternal fetal attachment at relevant gestational time-points. As a result of the knowledge gathered from this study, the investigators will be able to develop a specific intervention strategy to promote this fundamental process for egg donation families.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
132

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2022

Geographic Reach
3 countries

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2022

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

May 11, 2023

Completed
28 days until next milestone

First Posted

Study publicly available on registry

June 8, 2023

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2024

Completed
Last Updated

February 26, 2025

Status Verified

May 1, 2023

Enrollment Period

1.4 years

First QC Date

May 11, 2023

Last Update Submit

February 25, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • validated questionnaire to assess the change of maternal fetus attachment (MAAS)

    The MAAS total score is calculated by the sum of all item of the questionnaire, and the subscales score (quality and intensity of the attachment) are calculated through the sum of the rate of each item that is included in that scale. Scoring is 1-5, with 5 high attachment

    between 19-23 gestational weeks and follow up between 28-32 weeks of gestation

  • validated questionnaire to assess the change of Paternal fetus attachment (PAAS)

    The PAAS total score is calculated by the sum of all item of the questionnaire, and the subscales score (quality and intensity of the attachment) are calculated through the sum of the rate of each item that is included in that scale. Scoring is 1-5, with 5 high attachment

    between 19-23 gestational weeks and follow up between 28-32 weeks of gestation

  • questionnaire to explore the change of the Emotional status (Anxiety or depression feelings) during pregnancy (MGMQ)

    The MGMQ provideds a screen positive / negative classification of emotional distress

    between 19-23 gestational weeks and follow up between 28-32 weeks of gestation

Study Arms (2)

DONATED GAMETE GROUP

couples who got pregnant through egg donation (with their own semen)

Other: Questionnaires

OWN GAMETE GROUP

couples who got pregnant through standard IVF treatment, with their own gametes

Other: Questionnaires

Interventions

Questionnaires

DONATED GAMETE GROUPOWN GAMETE GROUP

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The reference population includes all couples who have become pregnant in the selected IVI RMA clinics , through egg donation or standard IVF treatment, being the woman 40 years old or above, with no other specific indications (except individuals taking psychotropic drugs). Their native language must be English or Italian.

You may qualify if:

  • getting pregnant through an egg donation program
  • Own semen
  • Native language must be English or Italian

You may not qualify if:

  • Patients failing to consent to be recontacted for research purpose.
  • Patients who are taking psychotropic drugs
  • Patients who got pregnant through sperm or embryo donation
  • OWN GAMETE GROUP
  • getting pregnant through a standard IVF treatment with own gametes
  • Native language must be English or Italian
  • Patients failing to consent to be recontacted for research purpose.
  • Patients who are taking psychotropic drugs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

IVI Roma

Roma, 00169, Italy

Location

IVI Foundation

Valencia, 46026, Spain

Location

IVI London

London, W1G 9RQ, United Kingdom

Location

MeSH Terms

Interventions

Surveys and Questionnaires

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 11, 2023

First Posted

June 8, 2023

Study Start

November 1, 2022

Primary Completion

March 30, 2024

Study Completion

March 30, 2024

Last Updated

February 26, 2025

Record last verified: 2023-05

Locations